Sezary syndrome Archives - Patient Worthy

<a href="https://pixabay.com/users/skeeze/">skeeze</a> / Pixabay

Experimental Treatment for Sézary Syndrome Earns Fast Track Designation

According to a story from pm360online.com, the drug developer Innate Pharma SA recently announced that its experimental therapy IPH4102 has been granted Fast Track designation from the US Food and…

A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases

Trudy Horsting
January 17, 2019
Amyloidosis / Dravet Syndrome / Fabry Disease / Lennox-Gastaut syndrome / Neurotrophic Keratopathy / Non-Hodgkin's Lymphoma / Sezary syndrome
0 Comments

Each year the Food and Drug Administration approves dozens of new therapies to fulfill unmet needs for various patient populations. It's just been published that in 2018 they approved a…

<a href="https://pixabay.com/users/padrinan/">padrinan</a> / Pixabay

The Progress of Cancer Treatment in 2018

James Moore
January 1, 2019
Acute Myeloid Leukemia / Hairy cell leukemia / mycosis fungoides / Sezary syndrome
0 Comments

Dr. Louis J. DeGennaro, who is the CEO and President of the Leukemia & Lymphoma Society, has recently contributed a blog post on the organization's website. In this post, Dr.…

Experimental Treatment for Sézary Syndrome Earns Fast Track Designation

A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases

The Progress of Cancer Treatment in 2018

Let’s Work Together!

Keep Up to Date

Learn More

SIGN UP FOR OUR NEWSLETTER
Email Address